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What is Pulmonary Fibrosis? 
● Chronic lung disease
○ Current ly no cure
○ Life expectancy of pat ients is usually less than 5 years
○ Scarring of lung t issues causing it  to become st iff and thickened
● Symptoms:
○ Difficulty breathing
○ Weight loss
○ Fat igue
Categorizat ion
● 4 stages of disease
○ Mild
○ Early 
○ Severe
○ Advanced
● GAP Index Evaluat ion
○ Places pat ients in the above stages based on these criterias
■ Age
■ Recent respiratory hospitalizat ion
■ Baseline Forced Vital Capacity  (FVC)
■ 24 Week change in FVC
Risk Factors
● Age
○ More likely to occur in middle-aged and older adults
● Smoking
○ More likely to occur in those who smoke
● Occupat ional and Environmental Factors
○ Exposure to pollutants and toxins
● Cancer Treatments
○ Radiat ion therapy in the chest area
○ Certain chemotherapy drugs
■ Methotrexate
■ Cyclophosphamide
Idiopathic Pulmonary Fibrosis
● When the cause of pulmonary fibrosis can not be pinpointed
○ The disease is called idiopathic pulmonary fibrosis
On a cel lular level
● Overproduct ion of type I collagen
● Aberrant proliferat ion of IPF fibroblasts
○ Resistance to  apoptosis
○ Higher cell viability
○ Altered cell signaling pathway
Proposed mechanism of Radiat ion Induced IPF
● Radiat ion causes decrease  in the expression level of FoxO3a
○ FoxO3a is a transcript ion factor
● Downregulat ion in FoxO3a causes upregulat ion in FoxM1
● Increase in FoxM1 causes higher expression levels of DNA repair proteins
○ DNA damage repair proteins:  BRCA2, Rad51, XRCC1
● Increase in DNA repair proteins leads to greater DNA repair act ivity
○ Allows the IPF  fibroblasts to proliferate aberrant ly 
○ DNA damage accumulates  in healthy fibroblasts 
■ Signals for apoptosis
■ Decrease of this signaling in IPF
Cell  Viabil ity 
● Control and IPF fibroblasts will be plated on polymerized collagen
● Both will then be  irradiated at 9 Gy
● Cell viability will be checked 3 days after radiat ion 
○ Performed using CellTiter-Blue cell viability assay
■ Reagent resazurin reduced to resorufin
■ The conversion generates fluorescent product
■ Fluorescence proport ional to number of viable cells
○ IPF fibroblasts should have higher fluorescence than control fibroblasts
Western Blot
● Both IPF and control fibroblasts will be plated on polymerized  collagen then 
irradiated
● Lysates will be collected at different time points after radiation  to observe how 
radiation alters protein expression as a result of time progression.
Predicted resul ts
Control Fibroblasts (as compared to IPF)
● Higher levels of FoxO3a 
● Lower levels of FoxM1 
● Lower levels of Brca2, Rad51, XRCC1
IPF Fibroblasts (as compared to control)
● Lower levels of FoxO3a
● Higher levels of FoxM1
● Higher levels of Brca2, Rad51, XRCC1
Future appl icat ions
● Pathway may be targeted in future drug development
● By finding a way to  stop  IPF fibroblasts proliferat ion
○ Potent ially stop disease progression
● As IPF current ly has no cure, studying its pathways will provide us with a better 
understanding of how the disease works and how we can stop it . 
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